Mayinglong Pharmaceutical Group Co Ltd
SSE:600993
Operating Margin
Mayinglong Pharmaceutical Group Co Ltd
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | CN |
Market Cap | 12B CNY |
Operating Margin |
14%
|
Country | JP |
Market Cap | 776 550.9T JPY |
Operating Margin |
-83%
|
Country | US |
Market Cap | 698.5B USD |
Operating Margin |
32%
|
Country | UK |
Market Cap | 440.4B GBP |
Operating Margin |
3%
|
Country | DK |
Market Cap | 3.8T DKK |
Operating Margin |
45%
|
Country | US |
Market Cap | 359.3B USD |
Operating Margin |
28%
|
Country | US |
Market Cap | 322.8B USD |
Operating Margin |
11%
|
Country | UK |
Market Cap | 186.8B GBP |
Operating Margin |
19%
|
Country | CH |
Market Cap | 179.8B CHF |
Operating Margin |
27%
|
Country | CH |
Market Cap | 173.2B CHF |
Operating Margin |
32%
|
Country | US |
Market Cap | 157B USD |
Operating Margin |
19%
|
Profitability Report
View the profitability report to see the full profitability analysis for Mayinglong Pharmaceutical Group Co Ltd.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Mayinglong Pharmaceutical Group Co Ltd's most recent financial statements, the company has Operating Margin of 14.3%.